Combination of Spirulina with glycyrrhizin prevents cognitive dysfunction in aged obese rats

Sowmya Madhavadas1, Sarada Subramanian1

  • 1Department of Neurochemistry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.

Abstract

Insights

The Spirulina and glycyrrhizin combination significantly improved cognitive function in obese aged rats. This treatment also reduced key metabolic markers, suggesting a potential to reverse age-related cognitive decline.

Area of Science:

  • Neuroscience
  • Metabolic research
  • Pharmacology

Background:

  • Obesity and aging are associated with cognitive decline.
  • Monosodium glutamate (MSG) can induce obesity and related metabolic disturbances in animal models.
  • Acetylcholinesterase (AChE) activity in the hippocampus is a marker for cognitive function.

Purpose of the Study:

  • To investigate the cognition-enhancing effects of combining Spirulina and glycyrrhizin.
  • To assess the impact of this combination on metabolic parameters in MSG-induced obese aged rats.

Main Methods:

  • Obesity was induced in rats using MSG, followed by an 18-month growth period.
  • Cognitive function was evaluated using the Barne's maze task and hippocampal AChE levels.
  • Rats were treated with Spirulina, glycyrrhizin, or their combination (SpGly) for 30 days.

Main Results:

  • The SpGly combination significantly reduced serum glucose, cholesterol, and leptin levels.
  • Cognitive functions were notably improved in the SpGly-treated group.
  • A significant reduction in hippocampal AChE activity was observed with the SpGly combination.

Conclusions:

  • The combination of Spirulina and glycyrrhizin shows potential in reversing cognitive dysfunction linked to aging and obesity.
  • SpGly may offer a therapeutic strategy for metabolic and cognitive impairments.